13
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Alternative Copper-Based Single-Atom Nanozyme with Superior Multienzyme Activities and NIR-II Responsiveness to Fight against Deep Tissue Infections

      research-article
      1 , 2 , * , , 1 , 2 , 3 , 1 , 2 , * , , 3 , 4 , * , , 1 , * ,
      Research
      AAAS

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Nanozymes are considered to represent a new era of antibacterial agents, while their antibacterial efficiency is limited by the increasing tissue depth of infection. To address this issue, here, we report a copper and silk fibroin (Cu-SF) complex strategy to synthesize alternative copper single-atom nanozymes (SAzymes) with atomically dispersed copper sites anchored on ultrathin 2D porous N-doped carbon nanosheets (CuN x -CNS) and tunable N coordination numbers in the CuN x sites ( x = 2 or 4). The CuN x -CNS SAzymes inherently possess triple peroxidase (POD)-, catalase (CAT)-, and oxidase (OXD)-like activities, facilitating the conversion of H 2O 2 and O 2 into reactive oxygen species (ROS) through parallel POD- and OXD-like or cascaded CAT- and OXD-like reactions. Compared to CuN 2-CNS, tailoring the N coordination number from 2 to 4 endows the SAzyme (CuN 4-CNS) with higher multienzyme activities due to its superior electron structure and lower energy barrier. Meanwhile, CuN x -CNS display strong absorption in the second near-infrared (NIR-II) biowindow with deeper tissue penetration, offering NIR-II-responsive enhanced ROS generation and photothermal treatment in deep tissues. The in vitro and in vivo results demonstrate that the optimal CuN 4-CNS can effectively inhibit multidrug-resistant bacteria and eliminate stubborn biofilms, thus exhibiting high therapeutic efficacy in both superficial skin wound and deep implant-related biofilm infections.

          Related collections

          Most cited references40

          • Record: found
          • Abstract: found
          • Article: not found

          Nanozyme: new horizons for responsive biomedical applications.

          Nanozymes are nanomaterial-based artificial enzymes. By effectively mimicking catalytic sites of natural enzymes or harboring multivalent elements for reactions, nanozyme systems have successfully served as direct surrogates of traditional enzymes for catalysis. With the rapid development and ever-deepening understanding of nanotechnology, nanozymes offer higher catalytic stability, ease of modification and lower manufacturing cost than protein enzymes. Additionally, nanozymes possess inherent nanomaterial properties, providing not only a simple substitute of enzymes but also a multimodal platform interfacing complex biologic environments. Recent extensive research has focused on designing various nanozyme systems that are responsive to one or multiple substrates by tailored means. Catalytic activities of nanozymes can be regulated by pH, H2O2 and glutathione concentrations and levels of oxygenation in different microenvironments. Moreover, nanozymes can be remotely-controlled via different stimuli, including a magnetic field, light, ultrasound, and heat. Collectively, these factors can be adjusted to maximize the diagnostic and therapeutic efficacies of different diseases in biomedical settings. Therefore, by integrating the catalytic property and inherent nanomaterial nature of nanozyme systems, we anticipate that stimuli-responsive nanozymes will open up new horizons for diagnosis, treatment, and theranostics.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Targeting microbial biofilms: current and prospective therapeutic strategies.

            Biofilm formation is a key virulence factor for a wide range of microorganisms that cause chronic infections. The multifactorial nature of biofilm development and drug tolerance imposes great challenges for the use of conventional antimicrobials and indicates the need for multi-targeted or combinatorial therapies. In this Review, we focus on current therapeutic strategies and those under development that target vital structural and functional traits of microbial biofilms and drug tolerance mechanisms, including the extracellular matrix and dormant cells. We emphasize strategies that are supported by in vivo or ex vivo studies, highlight emerging biofilm-targeting technologies and provide a rationale for multi-targeted therapies aimed at disrupting the complex biofilm microenvironment.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Copper active sites in biology.

                Bookmark

                Author and article information

                Journal
                Research (Wash D C)
                Research (Wash D C)
                RESEARCH
                Research
                AAAS
                2639-5274
                13 January 2023
                2023
                2023
                : 6
                : 0031
                Affiliations
                [ 1 ]Department of Orthopedic Surgery, Orthopedic Institute, The First Affiliated Hospital, Medical College, Soochow University , Suzhou, Jiangsu 215006, P. R. China.
                [ 2 ]Institute for Advanced Materials, School of Materials Science and Engineering, Jiangsu University , Zhenjiang, Jiangsu 212013, P. R. China.
                [ 3 ]Pharmaceutical Sciences Laboratory, Faculty of Science and Engineering, Åbo Akademi University , Turku 20520, Finland.
                [ 4 ]Turku Bioscience Centre, University of Turku and Åbo Akademi University , Turku 20520, Finland.
                Author notes
                Article
                0031
                10.34133/research.0031
                10076008
                37040491
                ae789340-faa8-4c4b-aa3d-00226456f697
                Copyright © 2023 Jiaxiang Bai et al.

                Exclusive licensee Science and Technology Review Publishing House. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution License 4.0 (CC BY 4.0).

                History
                : 01 November 2022
                : 05 December 2022
                : 13 January 2023
                Page count
                Figures: 6, Tables: 0, References: 40, Pages: 13
                Categories
                Research Article

                Comments

                Comment on this article